BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8524235)

  • 1. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.
    Arsura M; Deshpande A; Hann SR; Sonenshein GE
    Mol Cell Biol; 1995 Dec; 15(12):6702-9. PubMed ID: 8524235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
    FitzGerald MJ; Arsura M; Bellas RE; Yang W; Wu M; Chin L; Mann KK; DePinho RA; Sonenshein GE
    Oncogene; 1999 Apr; 18(15):2489-98. PubMed ID: 10229200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
    Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.
    Billaud M; Isselbacher KJ; Bernards R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2739-43. PubMed ID: 8464883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation by Myc is under negative control by the transcription factor AP-2.
    Gaubatz S; Imhof A; Dosch R; Werner O; Mitchell P; Buettner R; Eilers M
    EMBO J; 1995 Apr; 14(7):1508-19. PubMed ID: 7729426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and sequence of the feline max, and max 9 transcripts.
    Gallagher RC; Neil JC; Fulton R
    DNA Seq; 1995; 5(5):269-71. PubMed ID: 7579579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by the c-Myc helix-loop-helix/leucine zipper domain in mouse 3T3-L1 fibroblasts.
    Kohlhuber F; Hermeking H; Graessmann A; Eick D
    J Biol Chem; 1995 Dec; 270(48):28797-805. PubMed ID: 7499403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Blackwood EM; Eisenman RN
    Science; 1991 Mar; 251(4998):1211-7. PubMed ID: 2006410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic in vivo interactions among Myc network members.
    Yin X; Landay MF; Han W; Levitan ES; Watkins SC; Levenson RM; Farkas DL; Prochownik EV
    Oncogene; 2001 Aug; 20(34):4650-64. PubMed ID: 11498788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene.
    Walhout AJ; Gubbels JM; Bernards R; van der Vliet PC; Timmers HT
    Nucleic Acids Res; 1997 Apr; 25(8):1493-501. PubMed ID: 9162900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
    Ayer DE; Eisenman RN
    Genes Dev; 1993 Nov; 7(11):2110-9. PubMed ID: 8224841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
    Bousset K; Oelgeschläger MH; Henriksson M; Schreek S; Burkhardt H; Litchfield DW; Lüscher-Firzlaff JM; Lüscher B
    Cell Mol Biol Res; 1994; 40(5-6):501-11. PubMed ID: 7735324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
    Västrik I; Mäkelä TP; Koskinen PJ; Alitalo K
    Oncogene; 1995 Aug; 11(3):553-60. PubMed ID: 7630640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation.
    Mäkelä TP; Koskinen PJ; Västrik I; Alitalo K
    Science; 1992 Apr; 256(5055):373-7. PubMed ID: 1566084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Max: functional domains and interaction with c-Myc.
    Kato GJ; Lee WM; Chen LL; Dang CV
    Genes Dev; 1992 Jan; 6(1):81-92. PubMed ID: 1730412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a variant Max sequence expressed in Xenopus laevis.
    Tonissen KF; Krieg PA
    Oncogene; 1994 Jan; 9(1):33-8. PubMed ID: 8302600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
    Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
    EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.